ambrosia pollen
Allergenexperimental
Ambrosia artemisiifolia, with the common names common ragweed, annual ragweed, and low ragweed, is a species of the genus Ambrosia native to regions of the Americas. — Wikipedia
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started Oct 1, 2014 (NCT02256553)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Ambrosia artemisiifoliaImmunity, desensitized
Ambrosia artemisiifolia immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS63TBJ590BL ↗
- WikipediaAmbrosia artemisiifolia ↗
- NCATSU2AI3H2J5Y ↗
- NCATSRX18M46K8L ↗
- NCATSO4AB4546TP ↗
- NCATSM3S672G75O ↗
- NCATSKU1V1898XX ↗
- NCATS9W34L2CQ9A ↗
- NCATS81214Y871U ↗
- NCATS662J7FTA7T ↗
- NCATS57W5SO585B ↗
- NCATS2Z41EEQ491 ↗
- NCATSZIO18VN6HJ ↗
Also known as
- mk-3641
- mk-7243
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04742829 | N/A | Oct 1, 2020 | University of Molise |
| NCT02478398 | Phase 3 | Jul 20, 2015 | Merck |
| NCT02256553 | Phase 4 | Oct 1, 2014 | ALK-Abello, S.A., Merck |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 2 | 1 | 2 | 2014 |
| ALK-Abello, S.A. | For profit | 1 | 1 | 1 | 2014 |
| University of Molise | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1